Anemia: all 1,768 studies

Page 3 of 18. Open to participants first (244), then studies with results posted, then the rest; newest registration first within each.

• Impact of Intravenous Iron on Musculoskeletal Function in Older AdultsNot yet recruitingNCT05708170Phase 4
• Asses the Impact of Early Starting Erythropoetin in the Reduction of Transfusions Blood in ChildrensNot yet recruitingNCT05704894Phase 3
• Individualized or Conventional Transfusion Strategies During Peripheral VA-ECMORecruitingNCT05699005Phase 1
• Ibrutinib for the Treatment of AIHA in Patients With CLL/SLL or CLL-like MBLRecruitingNCT05694312Phase 2
• The Safety and Efficacy Study of Avatrombopag Switch in TPO-RA Refractory AARecruitingNCT05518331Not applicable
• A Post Marketing Surveillance to Evaluate the Safety of Desidustat for the Treatment of Anemia in Subjects With Chronic Kidney Disease (CKD).(Real World Evidence Study)RecruitingNCT05515367Phase 4
• GVHD Prophylaxis by Addition of CD20 Monoclonal Antibody to the Conditioning Regimen in SAA With Treatment of Allo-HSCTRecruitingNCT05510505Phase 2
• Intravenous Versus Oral Iron for Treating Iron-Deficiency Anemia in PregnancyRecruitingNCT05462704Phase 3
• Guideline Adherence for Preoperative Anemia Management in a PACRecruitingNCT05447442
• Primary Prevention of Stroke in Children With Sickle Cell Anaemia in Nigeria in the CommunityRecruitingNCT05434000Not applicable
• Up-front Matched Unrelated Donor Transplantation in Pediatric Patients With Idiopathic Aplastic AnemiaNot yet recruitingNCT05419843Phase 2
• Ferric Derisomaltose and Outcomes in the Recovery of Gynecologic Oncology: ERAS (Enhanced Recovery After Surgery)RecruitingNCT05407987Phase 3
• Autologous Tregs for Aplastic AnaemiaRecruitingNCT05386264Phase 1
• FGF23 and Cardiovascular Damage in Anemia With an Without Chronic Kidney Disease.RecruitingNCT05356325
• Effect of the Combined Programme on Perioperative Anaemia（CPPA）RecruitingNCT05353348Not applicable
• Darbe Plus IV Iron to Decrease Transfusions While Maintaining Iron Sufficiency in Preterm InfantsRecruitingNCT05340465Phase 2
• Study of DISC-0974 (RALLY-MF) in Participants With Myelofibrosis or Myelodysplastic Syndrome and AnemiaRecruitingNCT05320198Phase 1/2
• IV Iron Trial for Anemia Related to Uterine Bleeding in Female Patients Presenting to the Emergency DepartmentRecruitingNCT05304442Phase 3
• Intravenous Iron Infusion on Chemotherapy-induced AnemiaNot yet recruitingNCT05299411Phase 2
• Single-dose Intravenous Iron Therapy for Anemia After Orthopaedic TraumaRecruitingNCT05292001Phase 4
• Sucrosomial Iron vs. Oral Iron Sulfate for the Treatment of Iron Deficiency Anemia in Patients With Ulcerative ColitisRecruitingNCT05225545Phase 3
• The Predictive Capacity of Machine Learning Models for Progressive Kidney Disease in Individuals With Sickle Cell AnemiaRecruitingNCT05214105
• Chelated Oral Iron Versus Intravenous Iron Sucrose for Treatment of Iron Deficiency Anemia Late in PregnancyAvailableNCT05151679
• Patient Blood Management Charité (PBM-Charité): Structured Detection, Differentiated Diagnostics and Therapy of Preoperative Anemia and Use of Machine Autotransfusion in Elective InterventionsRecruitingNCT05146726
• Haploidentical Allogeneic Hematopoietic Stem Cell Transplantation With Post-transplant Cyclophosphamide in Patients With Acquired Refractory Aplastic Anemia or in Relapse After ImmunosuppressionRecruitingNCT05126849Phase 2
• Iron Supplementation in Upper Non-variceal Gastrointestinal BleedingNot yet recruitingNCT05060731Phase 4
• Second-line Treatment of Primary Autoimmune Hemolytic AnemiaRecruitingNCT05057468Phase 3
• RACE 2: a Long Term Follow-up of Patients Participating in the RACE TrialEnrolling by invitationNCT05049668
• A Study of Elritercept Alone or Together With Ruxolitinib in Adults With MyelofibrosisRecruitingNCT05037760Phase 2
• The Significance of Release of T-follicular Helper and T-follicular Regulatory Cells in Autoimmune Haemolytic Anemia Before and After TratmentNot yet recruitingNCT04814394
• Association Between Dapagliflozin-induced Improvement and Anemia in Heart Failure Patients (ADIDAS)RecruitingNCT04707261Phase 4
• IV Iron vs Oral Iron for Treatment of Anemia in Women With Abnormal Uterine BleedingRecruitingNCT04205266Phase 4
• Preoperative Intravenous Iron Therapy in Patients With Gastric CancerNot yet recruitingNCT04168346Phase 4
• A Phase 3 Open Label Extension Study of Fostamatinib Disodium in the Treatment of Warm Antibody Autoimmune Hemolytic AnemiaEnrolling by invitationNCT04138927Phase 3
• Impact of Intravenous Iron Treatment of Preoperative Anemia in Patients With LEAD (IRONPAD)RecruitingNCT04083755Phase 4
• Oral Iron in Children With Chronic Kidney DiseaseRecruitingNCT03991169Phase 4
• A Study to Evaluate Ferumoxytol for the Treatment of Iron Deficiency Anemia (IDA) in Pediatric SubjectsRecruitingNCT03893045Phase 3
• T-Cell Depleted Alternative Donor Bone Marrow Transplant for Sickle Cell Disease (SCD) and Other AnemiasRecruitingNCT03653338Phase 1/2
• Systemic Organ Communication in STEMIRecruitingNCT03539133
• Use Massive Parallel Sequencing and Exome Capture Technology to Sequence the Exome of Fanconi Anemia Children and Their PatentsAvailableNCT01995305
• Expanded Access Study of HBOC-201 (Hemopure) for the Treatment of Life-Threatening AnemiaEnrolling by invitationNCT01881503Not applicable
• Collection and Distribution of Samples From Healthy Donors for In Vitro Research at the NCI-FrederickEnrolling by invitationNCT00339911
• Diamond Blackfan Anemia Registry (DBAR)RecruitingNCT00106015
• Screening for Hematology Branch ProtocolsEnrolling by invitationNCT00001620
• Analyses of Anemia in Very Low Birth Weight (VLBW) Infants.CompletedNCT05949788Results posted
• Anemia Studies in CKD: Erythropoiesis Via a Novel PHI Daprodustat - Pediatric (ASCEND-P)CompletedNCT05682326Phase 3Results posted
• A Study of Etavopivat for the Treatment of Anemia in Patients With Myelodysplastic Syndromes (MDS)TerminatedNCT05568225Phase 2Results posted
• Hydroxyurea and EPO in Sickle Cell DiseaseCompletedNCT05451940Phase 1/2Results posted
• Practical Anemia Bundle for SusTained Blood RecoveryCompletedNCT05167734Phase 2Results posted
• Evaluate the Safety and Efficacy of Ferric Maltol Oral Suspension vs. Ferrous Sulfate Oral Liquid in Children and Adolescents Aged 2 to 17 Years With Iron-deficiency Anaemia, With a Single Arm Study in Infants Aged 1 Month to Less Than 2 YearsCompletedNCT05126901Phase 3Results posted
• Intravenous Iron vs. Oral Iron Supplementation for Postpartum AnemiaCompletedNCT05047211Phase 4Results posted
• Alternate Day Versus Daily Oral Iron Therapy in AdolescentsCompletedNCT05007899Phase 4Results posted
• An Efficacy and Safety Study of Luspatercept (ACE-536) Versus Placebo in Subjects With Myeloproliferative Neoplasm-Associated Myelofibrosis on Concomitant JAK2 Inhibitor Therapy and Who Require Red Blood Cell TransfusionsActive, not recruitingNCT04717414Phase 3Results posted
• Study Evaluating the Efficacy and Safety of Dose Conversion From a Long-acting Erythropoiesis-stimulating Agent (Mircera®) to Three Times Weekly Oral Vadadustat for the Maintenance Treatment of Anemia in Hemodialysis SubjectsCompletedNCT04707768Phase 3Results posted
• Safety, Pharmacokinetics, and Efficacy of Subcutaneous Isatuximab in Adults With Warm Autoimmune Hemolytic Anemia (wAIHA)TerminatedNCT04661033Phase 2Results posted
• A Study to Investigate the Effect of Roxadustat Versus Recombinant Human Erythropoietin (rHuEPO) on Oral Iron Absorption in Chinese Patients With Anemia of Chronic Kidney Disease (CKD)CompletedNCT04655027Phase 4Results posted
• A Study of TP-0184 to Treat Anemia in Adults With IPSS-R Low or Intermediate Risk MDSTerminatedNCT04623996Phase 1/2Results posted
• Daily Versus Alternate Day Iron Supplementation for the Treatment of Iron Deficiency Anemia in PregnancyTerminatedNCT04594070Phase 4Results posted
• To Assess the Safety and Tolerability of INCB000928 in Participants With Myelodysplastic Syndromes or Multiple MyelomaTerminatedNCT04582539Phase 1/2Results posted
• Study of Efficacy and Safety of Twice Daily Oral LNP023 in Adult PNH Patients With Residual Anemia Despite Anti-C5 Antibody TreatmentCompletedNCT04558918Phase 3Results posted
• Study of Roxadustat Conversion in Participants Receiving Stable ESA or as Initial Anemia Treatment in Hemodialysis ParticipantsCompletedNCT04484857Phase 3Results posted
• INCB000928 Administered as a Monotherapy or in Combination With Ruxolitinib in Participants With Anemia Due to Myeloproliferative DisordersCompletedNCT04455841Phase 1/2Results posted
• Study of Roxadustat Conversion in Participants Receiving Stable Erythropoiesis-Stimulating Agent (ESA) or as Initial Anemia Treatment in Chronic Dialysis ParticipantsCompletedNCT04410198Phase 3Results posted
• Oral Iron Versus Oral Iron Plus a Web-based Behavioral Intervention in Young Children (IRONCHILD)CompletedNCT04371536Phase 3Results posted
• A Study to Assess Efficacy and Safety of PF-06462700 in Japanese Participants With Aplastic AnemiaCompletedNCT04350606Phase 3Results posted
• Trial Evaluating the Efficacy and Safety of Oral Vadadustat Once Daily (QD) and Three Times Weekly (TIW) for the Maintenance Treatment of Anemia in Hemodialysis Subjects Converting From Erythropoiesis-Stimulating Agents (ESAs)CompletedNCT04313153Phase 3Results posted
• Treatment of Refractory Diamond-Blackfan Anemia With EltrombopagCompletedNCT04269889Phase 1/2Results posted
• Efficacy and Safety of Intravenous Ferric Carboxymaltose in Pediatric Patients With Iron Deficiency Anemia and Unsatisfactory Response Oral Iron Under Study Protocol 1VIT17044CompletedNCT04269707Phase 3Results posted
• To Assess the Efficacy and Safety of RVT-1401 in the Treatment of Warm Autoimmune Hemolytic Anemia (ASCEND-WAIHA).TerminatedNCT04253236Phase 2Results posted
• Use of Intravenous Ferric Carboxymaltose in Treatment of Anemia in Cancer Patients Undergoing ChemotherapyCompletedNCT04246021Not applicableResults posted
• Intra-patient Dose Escalation Study to Investigate Safety and Feasibility of Vactosertib in Treating Anemic MPN PatientsTerminatedNCT04103645Phase 2Results posted
• Evaluation of Efficacy and Safety of Roxadustat for the Treatment of Chemotherapy Induced AnemiaCompletedNCT04076943Phase 2Results posted
• Study of HEMAX PFS Versus EPREX/ ERYPO® in Predialysis Chronic Kidney DiseaseCompletedNCT04036253Phase 3Results posted
• Study to Test the Hypothesis of Non-inferior Efficacy and Safety of Ferrum Lek® (Iron (III) Hydroxide Polymaltosate), 100 mg Chewable Tablets (Lek d.d., Slovenia), as Compared With MALTOFER® (Vifor S.A., Switzerland), in Subjects With Mild and Moderate Iron Deficiency Anemia.CompletedNCT03993288Phase 3Results posted
• The Use of Trifluoperazine in Transfusion Dependent DBATerminatedNCT03966053Phase 1/2Results posted
• A Study to Assess the Safety and Pharmacokinetics of HBI-002, an Oral Carbon Monoxide Therapeutic, in Healthy VolunteersCompletedNCT03926819Phase 1Results posted
• An Efficacy and Safety Study of Luspatercept (ACE-536) for the Treatment of Anemia Due to IPSS-R Very Low, Low or Intermediate Risk Myelodysplastic Syndromes (MDS) in Japanese Subjects Who Are Not Requiring Red Blood Cell TransfusionCompletedNCT03900715Phase 2Results posted
• Mechanisms of EPO-induced HypertensionTerminatedNCT03810911Phase 2Results posted
• Study of Vadadustat in Hemodialysis Participants With Anemia Switching From Epoetin AlfaCompletedNCT03799627Phase 2Results posted
• A Phase 3, Multi-Center, Randomized, Double-Blind, Placebo-Controlled, Study of Fostamatinib Disodium in the Treatment of wAIHACompletedNCT03764618Phase 3Results posted
• Long Term Follow-up Study for Patients Enrolled on the BP-004 Clinical StudyTerminatedNCT03733249Phase 1/2Results posted
• Daily vs. Every Other Day Oral Iron Supplementation in Patients With Absolute Iron Deficiency AnemiaCompletedNCT03725384Phase 3Results posted
• A Study to Compare the Efficacy and Safety of Luspatercept (ACE-536) Versus Epoetin Alfa for the Treatment of Anemia Due to IPSS-R Very Low, Low, or Intermediate Risk Myelodysplastic Syndromes (MDS) Participants Who Require Red Blood Cell Transfusions and Are ESA NaïveActive, not recruitingNCT03682536Phase 3Results posted
• A Study of the Effect of Blood Stem Cell Transplant After Chemotherapy Alone in Patients With Fanconi AnemiaTerminatedNCT03600909Phase 2Results posted
• To Assess the Impact of Ferric Carboxymaltose Compared With Iron Sucrose in Chinese Subjects on Correcting Iron Deficiency AnaemiaCompletedNCT03591406Phase 3Results posted
• Ascertain the Optimal Starting Dose of Mircera Given Subcutaneously for Maintenance Treatment of Anemia in Pediatric Patients With Chronic Kidney Disease on Dialysis or Not Yet on Dialysis.CompletedNCT03552393Phase 2Results posted
• Multicenter Randomized Active-controlled Study to Investigate Efficacy & Safety of IV FCM in Pediatric Patients With IDACompletedNCT03523117Phase 3Results posted
• Comparative Study of the Efficacy and Safety of BCD-131 and Mircera in Treatment of Anemia in CKD Patients on DialysisCompletedNCT03519243Phase 2Results posted
• Conditioning Regimen for Allogeneic Hematopoietic Stem-Cell TransplantationCompletedNCT03513328Phase 1/2Results posted
• Association of Anemia With Hospital Costs in Elective Colorectal SurgeryCompletedNCT03476707Results posted
• Efficacy and Safety Study to Evaluate MT-6548 in Hemodialysis Subjects Not Receiving ESAs With Anemia Associated With Chronic Kidney Disease in JapanCompletedNCT03461146Phase 3Results posted
• Study to Evaluate the Efficacy & Safety of the INTERCEPT Blood System for RBCs in Complex Cardiac Surgery PatientsCompletedNCT03459287Phase 3Results posted
• Anemia Studies in CKD: Erythropoiesis Via a Novel Prolyl Hydroxylase Inhibitor (PHI) Daprodustat- Iron (ASCEND: Fe)CompletedNCT03457701Phase 2Results posted
• Anemia Study in Chronic Kidney Disease (CKD) : Erythropoiesis Via a Novel Prolyl Hydroxylase Inhibitor (PHI) Daprodustat -Forearm Blood Flow (ASCEND-FBF)TerminatedNCT03446612Phase 2Results posted
• Shared-Decision Making for HydroxyureaCompletedNCT03442114Not applicableResults posted
• Efficacy and Safety Study to Evaluate MT-6548 in Hemodialysis Subjects Currently Receiving ESAs With Anemia Associated With Chronic Kidney Disease in JapanCompletedNCT03439137Phase 3Results posted
• Intravenous Iron for Iron-deficiency Anemia in Pregnancy: a Randomized Controlled TrialCompletedNCT03438227Phase 4Results posted
• SMaRT Blood: Single-unit Versus Multiple-unit Packed Red Blood Cell Transfusion in Non-acute Postpartum AnemiaCompletedNCT03419780Not applicableResults posted
• Anemia Studies in Chronic Kidney Disease (CKD): Erythropoiesis Via a Novel Prolyl Hydroxylase Inhibitor (PHI) Daprodustat in Non-Dialysis Subjects Evaluating Hemoglobin (Hgb) and Quality of Life (ASCEND-NHQ)CompletedNCT03409107Phase 3Results posted
• Comparing Efficacy and Safety of CinnaGen Beta Erythropoietin (CinnaPoietin®) Versus Eprex® on the Treatment of Anemia in ESRD Hemodialysis PatientsCompletedNCT03408639Phase 3Results posted

← Anemia overview